Download Report

Media Release
For immediate release
October 21, 2014
DynaLIFEDx Seeks Information on AHS Decision to Award Australian Company Lab Services
Clarification important for Alberta Patients
Edmonton AB – October 21, 2014
Late last week, DynaLIFEDx (DL) was informed by Alberta Health Services that they had entered into
negotiations with Sonic Healthcare, an Australian based company to provide lab service for 15 years to
metro Edmonton as well as parts of central and northern Alberta. DL has been the provider of the lab
services for over 40 years. “This decision to enter into negotiations with Sonic raises a number of
significant questions for DL’s future and for its employees and patients,” says Jason Pincock, CEO of
DynaLIFEDx. DL is therefore seeking and has submitted a request for a debrief with AHS as soon as
possible.
DynaLIFEDx is an Alberta born enterprise headquartered in Edmonton that was established to serve the
needs of metro Edmonton and northern Albertans. “Having its corporate and operational base in
Edmonton has made it possible to respond successfully to the physicians and patients it serves. Our
decision making and business processes have been able to adapt to local needs,” says Pincock.
DynaLIFEDx has a record of patient satisfaction and exceptional labour relations as well as being
recognized as one of Alberta’s top employers and Canada’s Best Managed Companies. “We are a local
success story,” says Pincock. A top priority for DL in this whole process is the future of the staff who have
built this company and who work here every day.
Recent AHS comments and coverage provided information that requires clarification:
 DL is Alberta-based and a majority-owned Canadian company by Borealis Infrastructure (OMERS)
that is backed by Canadian pension funds and Canadian pensioners.
 DL has a minority American partner LabCorp, a world leader in specialty testing.
 DL is a leader in quality and is accredited by the College of Physicians and Surgeons of Alberta
and the College of American Pathologists.
 All proponents including DL were required to include provision for a new, state of the art lab facility
in their proposals. This facility was a mandatory requirement for all proposals and was not a feature
of the Sonic proposal alone. DL has partnered with local leaders PCL and Stantec in its proposal
for the new facility.
 Sonic is not the only company capable of providing specialty testing. Less than one percent of
current tests are completed outside Alberta. LabCorp, DL’s partner, is considered a world leader in
specialty testing such as genetics and is fully capable of supporting this testing in Alberta.
The transition is much more complex than taking over another company’s equipment and facilities. “We
require a comprehensive understanding of the transition plans AHS has publicly spoken about. It appears
that AHS assumes the transition is as simple as taking over a company’s experience, support structures,
systems – and most importantly, its people all without discussing this transition with DL,” says Pincock.
DynaLIFEDx remains committed to delivering the quality of service it has built its reputation upon without
interruption to its millions of patients.
More information:
Jason Pincock
Chief Executive Officer
(780) 451-3702
-30-
About DynaLIFEDx
DL is Alberta’s largest privately owned Clinical Laboratory. DL is headquartered in Edmonton and
employs over 1200 medical, technical, and support staff in Edmonton and throughout central and
Northern Alberta. DL performs over 15 Million publicly funded laboratory tests annually for 1.5 Million
Albertans in its state of the art laboratories. DL is recognized as one of Canada’s Best Managed
Companies and is recognized consistently as one of Alberta’s Top 65 Employers. DL is accredited by the
College of Physicians and Surgeons of Alberta and carries international accreditation through the College
of American Pathologists. DL is a key training facility for laboratory training in Western Canada. For more
information please visit: www.dynalifedx.com
About OMERS
OMERS is one of Canada's largest pension funds with over $65 billion in net assets. It provides first-class
pension administration and innovative products and services to over 440,000 members. Through the
OMERS Worldwide brand, our team of investment professionals uses a direct drive, active management
investment strategy to invest in public and private market assets, including publicly-traded equities, fixedincome, infrastructure, private equity and real estate. For more information, please visit:
www.omersworldwide.com
About Borealis Infrastructure
Borealis is the infrastructure investment arm of OMERS, one of Canada's largest pension funds with net
assets of more than $65 billion and an AAA credit rating. Borealis is a leader in direct infrastructure
investing with over a decade of investment experience. Borealis manages more than $11 billion in
OMERS equity capital through investments in a diversified portfolio of large-scale infrastructure assets
exhibiting stability and strong cash flows, in sectors including energy, transportation and governmentregulated services. For more information please visit: www.borealis.ca
About LabCorp®
Laboratory Corporation of America® Holdings, an S&P 500 company, is a pioneer in
commercializing new diagnostic technologies and the first in its industry to embrace genomic
testing. With annual revenues of $5.8 billion in 2013, over 34,000 employees worldwide, and
more than 220,000 clients, LabCorp offers more than 4,000 diagnostic tests ranging from
routine blood analyses to reproductive genetics to companion diagnostics. LabCorp furthers its
scientific expertise and innovative clinical testing technology through its LabCorp Specialty
Testing Group: The Center for Molecular Biology and Pathology, National Genetics Institute,
ViroMed Laboratories, Inc, The Center for Esoteric Testing, Litholink Corporation, Integrated
Genetics, Integrated Oncology, Dianon Pathology, Monogram Biosciences, Inc, Colorado
Coagulation, Cellmark Forensics, MedTox, and Endocrine Sciences. LabCorp conducts clinical
trials testing through its LabCorp Clinical Trials division. LabCorp clients include physicians,
government agencies, managed care organizations, hospitals, clinical labs, and pharmaceutical
companies. To learn more about our organization, visit our website at: www.labcorp.com